Literature DB >> 16315570

Development and psychometric testing of the Relational Care Scale.

Katherine S McGilton1, Dorothy M Pringle, Linda L O'Brien-Pallas, Francine Wynn, David Streiner.   

Abstract

The purpose of this article is to report the development and testing of the self-report Relational Care Scale (RCS). The RCS was specifically designed to evaluate the relational care that nursing staff provides to residents living in nursing homes. The scale's content validity was assessed with the assistance of experts and related research in the area of nurse-resident interactions, and then the scale was pilot tested with 30 residents of a long-term care (LTC) facility to determine its clarity and stability. The 6-item scale was then administered to a sample of 50 residents in an intervention study and then to 72 residents in a correlational study in two other LTC facilities in Ontario, Canada. Construct validity was demonstrated with positive correlations between RCS scores and a Relationship VAS measure (r = .63, p < .0001) and between RCS scores and an observational Relational Behavior Scale (r = .42, p < .001), which was also developed to assess relational care. Study results demonstrated that the RCS is a reliable and valid instrument that may be used to measure relational care to test interventions focusing on enhancing the relational care staff provides to residents.

Mesh:

Year:  2005        PMID: 16315570     DOI: 10.1891/jnum.2005.13.1.51

Source DB:  PubMed          Journal:  J Nurs Meas        ISSN: 1061-3749


  2 in total

1.  Patient-centred communication intervention study to evaluate nurse-patient interactions in complex continuing care.

Authors:  Katherine S McGilton; Riva Sorin-Peters; Souraya Sidani; Veronique Boscart; Mary Fox; Elizabeth Rochon
Journal:  BMC Geriatr       Date:  2012-10-11       Impact factor: 3.921

2.  Observational Evidence of For-Profit Delivery and Inferior Nursing Home Care: When Is There Enough Evidence for Policy Change?

Authors:  Lisa A Ronald; Margaret J McGregor; Charlene Harrington; Allyson Pollock; Joel Lexchin
Journal:  PLoS Med       Date:  2016-04-19       Impact factor: 11.069

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.